April 30, 2018

THERATECHNOLOGIES ANNOUNCES THAT TROGARZOTM (IBALIZUMAB-UIYK) INJECTION IS NOW AVAILABLE IN THE U.S.

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that its novel antiretroviral TrogarzoTM is now commercially available in the United States. TrogarzoTM is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 failing their current antiretroviral regimen.